News
President Donald Trump threatened to levy tariffs of up to 250% on pharmaceuticals imported into the United States.
Pfizer's Albert Bourla told investors that major drugmakers are "ready to roll up their sleeves" and build out more direct-to ...
Welcome to Contract Pharma’s annual ranking of the Top 20 Pharma and Biopharma Companies, based on fiscal year 2024 ...
Millions of people are alive today because of leukemia therapies that arose from UC research, including retired Army Major ...
Pfizer said its full-year profit should benefit from cost cuts across its research and manufacturing operations after posting ...
U.S. President Donald Trump said on Tuesday that the United States would initially place a “small tariff” on pharmaceutical ...
Tariffs would disrupt international supply chains, forcing companies to decide whether to pass on increased costs to patients ...
The recent U.S. decision to impose a 39% levy stunned the Alpine nation and upended months of negotiations. A private gauge of China's services sector showed activity expanded at the fastest pace in ...
Trump’s drug and chip tariffs could reshape supply chains before they launch. Here’s how escalating rates and hidden costs ...
LONG BEACH, Calif. -- Depletion of a payment assistance program has translated into worse vision outcomes for older patients ...
Investors must now underwrite opportunities with a “financing risk first” mindset, says Siddhi Capital cofounder Steven Finn.
Trump says Texas is ‘entitled to five more seats’ as DNC chair readies for ‘knife fight’: Live updates - President weighed in on Texas redistricting furore in CNBC interview on Tuesday morning as Demo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results